Healthcare Stocks Become Anti-AI Bet as Investors Turn Defensive
The S&P 500 Healthcare Index has risen about 23% since the end of April through Monday's close, outperforming every other sector, as investors turn defensive amid pressure on the AI trade. Eli Lilly, AbbVie and Johnson & Johnson have led the rally. The Nasdaq fell 4.5% last week as investors questioned AI spending, financing costs and valuations.